Global Kidney Cancer Therapeutics and Diagnostics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Kidney Cancer Therapeutics and Diagnostics market size will reach US$ million by 2031.
The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC).Immunotherapies or targeted therapies are the most common prescribed treatments for kidney cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Kidney Cancer Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Kidney Cancer Therapeutics and Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Kidney Cancer Therapeutics and Diagnostics sales for 2025 through 2031. With Kidney Cancer Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Cancer Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Kidney Cancer Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Kidney Cancer Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Kidney Cancer Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Cancer Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Cancer Therapeutics and Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The occurrence of kidney cancer has increased in the recent years. Excessive smoking, rise in obesity because of sedentary life routines and increased consumption of alcohol are some of the causes of kidney cancer. The most common type of cancer is Renal Cell Carcinoma (RCC).Immunotherapies or targeted therapies are the most common prescribed treatments for kidney cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Kidney Cancer Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Kidney Cancer Therapeutics and Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Kidney Cancer Therapeutics and Diagnostics sales for 2025 through 2031. With Kidney Cancer Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Kidney Cancer Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Kidney Cancer Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Kidney Cancer Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Kidney Cancer Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Kidney Cancer Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Kidney Cancer Therapeutics and Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Kidney Cancer Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cystoscopy
- Biopsy
- Intravenous Pyelogram
- CT Scan
- Kidney Ultrasound
- Others
- Hospitals
- Pharmaceutical Labs
- Genomics Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Hoffmann La Roche
- GlaxoSmithKline
- Novartis
- Pfizer
- Abbott Laboratories
- Amgen
- Genentech
- Cerulean Pharma
- Seattle Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size (2020-2031)
2.1.2 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Kidney Cancer Therapeutics and Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Kidney Cancer Therapeutics and Diagnostics Segment by Type
2.2.1 Cystoscopy
2.2.2 Biopsy
2.2.3 Intravenous Pyelogram
2.2.4 CT Scan
2.2.5 Kidney Ultrasound
2.2.6 Others
2.3 Kidney Cancer Therapeutics and Diagnostics Market Size by Type
2.3.1 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Kidney Cancer Therapeutics and Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Pharmaceutical Labs
2.4.3 Genomics Laboratories
2.4.4 Others
2.5 Kidney Cancer Therapeutics and Diagnostics Market Size by Application
2.5.1 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
3 KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Player
3.1.1 Global Kidney Cancer Therapeutics and Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS BY REGION
4.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025)
4.2 Global Kidney Cancer Therapeutics and Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.4 APAC Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.5 Europe Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025)
5.2 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
5.3 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025)
6.2 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
6.3 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025)
7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.3 APAC Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.4 Europe Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Forecast
10.2 Americas Kidney Cancer Therapeutics and Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.2 Canada Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.3 Mexico Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.4 Brazil Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3 APAC Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.3.1 China Kidney Cancer Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.3 Korea Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.4 Southeast Asia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.5 India Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.6 Australia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4 Europe Kidney Cancer Therapeutics and Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.2 France Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.3 UK Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.4 Italy Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.5 Russia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.2 South Africa Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.3 Israel Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.4 Turkey Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.6 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Type (2026-2031)
10.7 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Kidney Cancer Therapeutics and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Kidney Cancer Therapeutics and Diagnostics Product Offered
11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Hoffmann La Roche
11.2.1 Hoffmann La Roche Company Information
11.2.2 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product Offered
11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hoffmann La Roche Main Business Overview
11.2.5 Hoffmann La Roche Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product Offered
11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Kidney Cancer Therapeutics and Diagnostics Product Offered
11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Kidney Cancer Therapeutics and Diagnostics Product Offered
11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product Offered
11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Kidney Cancer Therapeutics and Diagnostics Product Offered
11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Genentech
11.8.1 Genentech Company Information
11.8.2 Genentech Kidney Cancer Therapeutics and Diagnostics Product Offered
11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Genentech Main Business Overview
11.8.5 Genentech Latest Developments
11.9 Cerulean Pharma
11.9.1 Cerulean Pharma Company Information
11.9.2 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product Offered
11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cerulean Pharma Main Business Overview
11.9.5 Cerulean Pharma Latest Developments
11.10 Seattle Genetics
11.10.1 Seattle Genetics Company Information
11.10.2 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product Offered
11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Seattle Genetics Main Business Overview
11.10.5 Seattle Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size (2020-2031)
2.1.2 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Kidney Cancer Therapeutics and Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Kidney Cancer Therapeutics and Diagnostics Segment by Type
2.2.1 Cystoscopy
2.2.2 Biopsy
2.2.3 Intravenous Pyelogram
2.2.4 CT Scan
2.2.5 Kidney Ultrasound
2.2.6 Others
2.3 Kidney Cancer Therapeutics and Diagnostics Market Size by Type
2.3.1 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Kidney Cancer Therapeutics and Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Pharmaceutical Labs
2.4.3 Genomics Laboratories
2.4.4 Others
2.5 Kidney Cancer Therapeutics and Diagnostics Market Size by Application
2.5.1 Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
3 KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Player
3.1.1 Global Kidney Cancer Therapeutics and Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS BY REGION
4.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025)
4.2 Global Kidney Cancer Therapeutics and Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.4 APAC Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.5 Europe Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025)
5.2 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
5.3 Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025)
6.2 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
6.3 APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025)
7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.3 APAC Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.4 Europe Kidney Cancer Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Forecast
10.2 Americas Kidney Cancer Therapeutics and Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.2 Canada Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.3 Mexico Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.2.4 Brazil Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3 APAC Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.3.1 China Kidney Cancer Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.3 Korea Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.4 Southeast Asia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.5 India Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.3.6 Australia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4 Europe Kidney Cancer Therapeutics and Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.2 France Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.3 UK Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.4 Italy Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.4.5 Russia Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.2 South Africa Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.3 Israel Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.5.4 Turkey Market Kidney Cancer Therapeutics and Diagnostics Forecast
10.6 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Type (2026-2031)
10.7 Global Kidney Cancer Therapeutics and Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Kidney Cancer Therapeutics and Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Kidney Cancer Therapeutics and Diagnostics Product Offered
11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Hoffmann La Roche
11.2.1 Hoffmann La Roche Company Information
11.2.2 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product Offered
11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Hoffmann La Roche Main Business Overview
11.2.5 Hoffmann La Roche Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product Offered
11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Kidney Cancer Therapeutics and Diagnostics Product Offered
11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Kidney Cancer Therapeutics and Diagnostics Product Offered
11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product Offered
11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Kidney Cancer Therapeutics and Diagnostics Product Offered
11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 Genentech
11.8.1 Genentech Company Information
11.8.2 Genentech Kidney Cancer Therapeutics and Diagnostics Product Offered
11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Genentech Main Business Overview
11.8.5 Genentech Latest Developments
11.9 Cerulean Pharma
11.9.1 Cerulean Pharma Company Information
11.9.2 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product Offered
11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Cerulean Pharma Main Business Overview
11.9.5 Cerulean Pharma Latest Developments
11.10 Seattle Genetics
11.10.1 Seattle Genetics Company Information
11.10.2 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product Offered
11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Seattle Genetics Main Business Overview
11.10.5 Seattle Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Kidney Cancer Therapeutics and Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cystoscopy
Table 4. Major Players of Biopsy
Table 5. Major Players of Intravenous Pyelogram
Table 6. Major Players of CT Scan
Table 7. Major Players of Kidney Ultrasound
Table 8. Major Players of Others
Table 9. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Table 12. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Table 15. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player (2020-2025)
Table 17. Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 18. Kidney Cancer Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Table 23. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country (2020-2025)
Table 27. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Table 29. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Table 31. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Table 33. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country (2020-2025)
Table 37. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Kidney Cancer Therapeutics and Diagnostics
Table 43. Key Market Challenges & Risks of Kidney Cancer Therapeutics and Diagnostics
Table 44. Key Industry Trends of Kidney Cancer Therapeutics and Diagnostics
Table 45. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Bayer Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 50. Bayer Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 51. Bayer Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Bayer Main Business
Table 53. Bayer Latest Developments
Table 54. Hoffmann La Roche Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 55. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 56. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Hoffmann La Roche Main Business
Table 58. Hoffmann La Roche Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 60. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 61. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. GlaxoSmithKline Main Business
Table 63. GlaxoSmithKline Latest Developments
Table 64. Novartis Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 65. Novartis Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 66. Novartis Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Novartis Main Business
Table 68. Novartis Latest Developments
Table 69. Pfizer Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 70. Pfizer Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 71. Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. Abbott Laboratories Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 75. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 76. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Amgen Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 80. Amgen Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 81. Amgen Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Amgen Main Business
Table 83. Amgen Latest Developments
Table 84. Genentech Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 85. Genentech Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 86. Genentech Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Genentech Main Business
Table 88. Genentech Latest Developments
Table 89. Cerulean Pharma Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 90. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 91. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Cerulean Pharma Main Business
Table 93. Cerulean Pharma Latest Developments
Table 94. Seattle Genetics Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 95. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 96. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Seattle Genetics Main Business
Table 98. Seattle Genetics Latest Developments
Table 1. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Kidney Cancer Therapeutics and Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cystoscopy
Table 4. Major Players of Biopsy
Table 5. Major Players of Intravenous Pyelogram
Table 6. Major Players of CT Scan
Table 7. Major Players of Kidney Ultrasound
Table 8. Major Players of Others
Table 9. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Table 12. Kidney Cancer Therapeutics and Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 14. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Table 15. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 16. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player (2020-2025)
Table 17. Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 18. Kidney Cancer Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 22. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Table 23. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country (2020-2025)
Table 27. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Table 29. Americas Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Table 31. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Table 33. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country (2020-2025)
Table 37. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Kidney Cancer Therapeutics and Diagnostics
Table 43. Key Market Challenges & Risks of Kidney Cancer Therapeutics and Diagnostics
Table 44. Key Industry Trends of Kidney Cancer Therapeutics and Diagnostics
Table 45. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global Kidney Cancer Therapeutics and Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Bayer Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 50. Bayer Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 51. Bayer Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Bayer Main Business
Table 53. Bayer Latest Developments
Table 54. Hoffmann La Roche Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 55. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 56. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Hoffmann La Roche Main Business
Table 58. Hoffmann La Roche Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 60. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 61. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. GlaxoSmithKline Main Business
Table 63. GlaxoSmithKline Latest Developments
Table 64. Novartis Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 65. Novartis Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 66. Novartis Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Novartis Main Business
Table 68. Novartis Latest Developments
Table 69. Pfizer Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 70. Pfizer Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 71. Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. Abbott Laboratories Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 75. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 76. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Amgen Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 80. Amgen Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 81. Amgen Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Amgen Main Business
Table 83. Amgen Latest Developments
Table 84. Genentech Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 85. Genentech Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 86. Genentech Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Genentech Main Business
Table 88. Genentech Latest Developments
Table 89. Cerulean Pharma Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 90. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 91. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Cerulean Pharma Main Business
Table 93. Cerulean Pharma Latest Developments
Table 94. Seattle Genetics Details, Company Type, Kidney Cancer Therapeutics and Diagnostics Area Served and Its Competitors
Table 95. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product Offered
Table 96. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Seattle Genetics Main Business
Table 98. Seattle Genetics Latest Developments
LIST OF FIGURES
Figure 1. Kidney Cancer Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Kidney Cancer Therapeutics and Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Kidney Cancer Therapeutics and Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Kidney Cancer Therapeutics and Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type in 2024
Figure 10. Kidney Cancer Therapeutics and Diagnostics in Hospitals
Figure 11. Global Kidney Cancer Therapeutics and Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Kidney Cancer Therapeutics and Diagnostics in Pharmaceutical Labs
Figure 13. Global Kidney Cancer Therapeutics and Diagnostics Market: Pharmaceutical Labs (2020-2025) & ($ millions)
Figure 14. Kidney Cancer Therapeutics and Diagnostics in Genomics Laboratories
Figure 15. Global Kidney Cancer Therapeutics and Diagnostics Market: Genomics Laboratories (2020-2025) & ($ millions)
Figure 16. Kidney Cancer Therapeutics and Diagnostics in Others
Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application in 2024
Figure 19. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player in 2024
Figure 20. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. APAC Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Europe Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Americas Kidney Cancer Therapeutics and Diagnostics Value Market Share by Country in 2024
Figure 26. United States Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region in 2024
Figure 31. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 33. China Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country in 2024
Figure 40. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. APAC Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Europe Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. United States Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Canada Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. China Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Japan Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Korea Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. India Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Australia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Germany Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. France Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. UK Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Italy Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Russia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Israel Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 1. Kidney Cancer Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Kidney Cancer Therapeutics and Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Kidney Cancer Therapeutics and Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Kidney Cancer Therapeutics and Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type in 2024
Figure 10. Kidney Cancer Therapeutics and Diagnostics in Hospitals
Figure 11. Global Kidney Cancer Therapeutics and Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Kidney Cancer Therapeutics and Diagnostics in Pharmaceutical Labs
Figure 13. Global Kidney Cancer Therapeutics and Diagnostics Market: Pharmaceutical Labs (2020-2025) & ($ millions)
Figure 14. Kidney Cancer Therapeutics and Diagnostics in Genomics Laboratories
Figure 15. Global Kidney Cancer Therapeutics and Diagnostics Market: Genomics Laboratories (2020-2025) & ($ millions)
Figure 16. Kidney Cancer Therapeutics and Diagnostics in Others
Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application in 2024
Figure 19. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Player in 2024
Figure 20. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. APAC Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Europe Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Americas Kidney Cancer Therapeutics and Diagnostics Value Market Share by Country in 2024
Figure 26. United States Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region in 2024
Figure 31. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 33. China Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Country in 2024
Figure 40. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Kidney Cancer Therapeutics and Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. APAC Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Europe Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. United States Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Canada Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. China Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Japan Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Korea Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. India Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Australia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Germany Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. France Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. UK Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Italy Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Russia Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Israel Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Kidney Cancer Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Kidney Cancer Therapeutics and Diagnostics Market Size 2026-2031 ($ millions)
More Publications
Global SMB Integrated Security Appliances Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
99 pages
Global GMP Plasmid DNA Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
88 pages
Global Vitamin B1 (Thiamine Mononitrate) Market Growth 2025-2031
US$ 3,660.00
December 2024
75 pages
